共 50 条
- [41] Randomized, Multicenter, Phase 3 Study of Accelerated Fraction Radiation Therapy With Concomitant Boost to the Gross Tumor Volume Compared With Conventional Fractionation in Concurrent Chemoradiation in Patients With Unresectable Stage III Non-Small Cell Lung Cancer: The Korean Radiation Oncology Group 09-03 Trial [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 115 (04): : 873 - 885
- [42] A PHASE II COMPARATIVE STUDY OF GROSS TUMOR VOLUME DEFINITION WITH OR WITHOUT PET/CT FUSION IN DOSIMETRIC PLANNING FOR NON-SMALL-CELL LUNG CANCER (NSCLC): PRIMARY ANALYSIS OF RADIATION THERAPY ONCOLOGY GROUP (RTOG) 0515 [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (01): : 435 - 441
- [43] A Phase II Comparative Study of Gross Tumor Volume Definition with or without PET/CT Fusion in Dosimetric Planning for Non-small-cell Lung Cancer (NSCLC): Primary Analysis of Radiation Therapy Oncology Group (RTOG) 0515 [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S2 - S2
- [44] A PHASE II STUDY OF SYNCHRONOUS THREE-DIMENSIONAL CONFORMAL BOOST TO THE GROSS TUMOR VOLUME FOR PATIENTS WITH UNRESECTABLE STAGE III NON-SMALL-CELL LUNG CANCER: RESULTS OF KOREAN RADIATION ONCOLOGY GROUP 0301 STUDY [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 74 (05): : 1397 - 1404
- [45] Predicting personalised and progressive adaptive dose escalation to gross tumour volume using knowledge-based planning models for inoperable advanced-stage non-small cell lung cancer patients treated with volumetric modulated arc therapy [J]. BIOMEDICAL PHYSICS & ENGINEERING EXPRESS, 2022, 8 (03)
- [46] Radiation Dose-Escalation to the Gross Tumor Volume Using Simultaneous Integrated Boost Intensity Modulated Photon or Proton Therapy With Concurrent Chemotherapy for Stage II-III Non-Small Cell Lung Cancer: A Preliminary Report of a Phase 1 Protocol [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S88 - S88
- [49] Increasing tumor volume is predictive of poor overall and progression-free survival: Secondary analysis of the radiation therapy oncology group 93-11 phase I-II radiation dose-escalation study in patients with inoperable non-small-cell lung cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (02): : 385 - 390
- [50] Increasing tumor volume is predictive of poor overall- and progression free survival: Secondary analysis of the Radiation Therapy Oncology Group (RTOG) 93-11 Phase I-II radiation dose escalation study in patients with inoperable non-small cell lung cancer (NSCLC) [J]. LUNG CANCER, 2005, 49 : S103 - S103